Literature DB >> 19953711

Predicting the risk of perioperative transfusion for patients undergoing elective hepatectomy.

Camelia S Sima1, William R Jarnagin, Yuman Fong, Elena Elkin, Mary Fischer, David Wuest, Michael D'Angelica, Ronald P DeMatteo, Leslie H Blumgart, Mithat Gönen.   

Abstract

OBJECTIVE: To develop 2 instruments that predict the probability of perioperative red blood cell transfusion in patients undergoing elective liver resection for primary and secondary tumors. SUMMARY BACKGROUND DATA: Hepatic resection is the most effective treatment for several benign and malign conditions, but may be accompanied by substantial blood loss and the need for perioperative transfusions. While blood conservation strategies such as autologous blood donation, acute normovolemic hemodilution, or cell saver systems are available, they are economically efficient only if directed toward patients with a high risk of transfusion.
METHODS: Using preoperative data from 1204 consecutive patients who underwent liver resection between 1995 and 2000 at Memorial Sloan- Kettering Cancer Center, we modeled the probability of perioperative red blood cell transfusion. We used the resulting model, validated on an independent dataset (n = 555 patients), to develop 2 prediction instruments, a nomogram and a transfusion score, which can be easily implemented into clinical practice.
RESULTS: The planned number of liver segments resected, concomitant extrahepatic organ resection, a diagnosis of primary liver malignancy, as well as preoperative hemoglobin and platelets levels predicted the probability of perioperative red blood cell transfusion. The predictions of the model appeared accurate and with good discriminatory abilities, generating an area under the receiver operating characteristic curve of 0.71.
CONCLUSIONS: Preoperative factors can be combined into risk profiles to predict the likelihood of transfusion during or after elective liver resection. These predictions, easy to calculate in the frame of a nomogram or of a transfusion score, can be used to identify patients who are at high risk for red cell transfusions and therefore most likely to benefit from blood conservation techniques.

Entities:  

Mesh:

Year:  2009        PMID: 19953711     DOI: 10.1097/sla.0b013e3181b7fad3

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

Review 1.  Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma.

Authors:  Hisashi Nakayama; Tadatoshi Takayama
Journal:  World J Hepatol       Date:  2015-02-27

2.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  No impact of perioperative blood transfusion on prognosis after curative resection for hepatocellular carcinoma: a propensity score matching analysis.

Authors:  T Peng; G Zhao; L Wang; J Wu; H Cui; Y Liang; R Zhou; Z Liu; Q Wang
Journal:  Clin Transl Oncol       Date:  2017-10-27       Impact factor: 3.405

4.  Validation of a Nomogram to Predict the Risk of Perioperative Blood Transfusion for Liver Resection.

Authors:  Fabio Bagante; Gaya Spolverato; Andrea Ruzzenente; Ana Wilson; Faiz Gani; Simone Conci; Alexander Yahanda; Tommaso Campagnaro; Alfredo Guglielmi; Timothy M Pawlik
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

5.  Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria.

Authors:  Chuan Li; Xiao-Yun Zhang; Wei Peng; Tian-Fu Wen; Lu-Nan Yan; Bo Li; Jia-Yin Yang; Wen-Tao Wang; Ming-Qing Xu
Journal:  World J Surg       Date:  2018-06       Impact factor: 3.352

6.  Validation of biological and clinical outcome between with and without thoracotomy in liver resection: a matched cohort study.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Masamichi Moriguchi; Shunji Okada; Yuki Hayashi; Hisashi Nakayama; Tokio Higaki; Masahiko Sugitani
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

7.  Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence?

Authors:  Raphael Lc Araujo; Carlos Andrés Pantanali; Luciana Haddad; Joel Avancini Rocha Filho; Luiz Augusto Carneiro D'Albuquerque; Wellington Andraus
Journal:  World J Gastrointest Surg       Date:  2016-02-27

8.  A decision model and cost analysis of intra-operative cell salvage during hepatic resection.

Authors:  Madeline Lemke; Gareth Eeson; Yulia Lin; Jordan Tarshis; Julie Hallet; Natalie Coburn; Calvin Law; Paul J Karanicolas
Journal:  HPB (Oxford)       Date:  2016-03-09       Impact factor: 3.647

9.  Intraoperative cell salvage with autologous transfusion in elective right or repeat hepatectomy: a propensity-score-matched case-control analysis.

Authors:  Thomas Zacharias; Erich Ahlschwede; Nicole Dufour; Florence Romain; Odile Theissen-Laval
Journal:  Can J Surg       Date:  2018-04       Impact factor: 2.089

10.  Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity.

Authors:  John Wehry; Steven Agle; Prejesh Philips; Robert Cannon; Charles R Scoggins; Lisa Puffer; Kelly M McMasters; Robert C G Martin
Journal:  Am J Surg       Date:  2015-09-30       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.